Translational and Regenerative Medicine

TOPCAT Trial Tests Possible Treatment for Patients with Heart Failure and Preserved Heart Pump Function

Can Spironolactone, a drug with multiple actions on the heart and blood vessels, improve outcomes in a hard-to-treat group of heart failure patients? This was a question addressed by the “Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT)” trial.

UA Sarver Heart Center Expert Offers Insights into New Uses of a Surgical Adhesive in New England Journal of Medicine

[Marvin Slepian, MD, with University of Arizona President Ann Weaver Hart and another gentleman]

[Marvin Slepian, MD, with University of Arizona President Ann Weaver Hart and another gentleman]Rapid advances in minimally invasive and catheter cardiovascular technologies have created a growing need for the development of effective adhesives that facilitate the deployment of these technologies while adequately controlling blood-clotting and bl

UACC Study Works to Improve Breast Cancer Treatment by Combining Nutrition and Medicine

University of Arizona Cancer Center researchers are continuing to seek participants for a study designed to determine if a compound found in broccoli can enhance the health-promoting effects of the breast cancer drug Tamoxifen in women at risk of developing breast cancer or those previously treated for early-stage breast cancer.

Bashas’ and K-LOVE 88.1 kick off breast cancer awareness drive Oct. 1 to benefit University of Arizona Cancer Center breast cancer research

Throughout the month of October, nationally known as Breast Cancer Awareness Month, Bashas’ and K-LOVE 88.1 have joined forces to conduct a breast cancer awareness drive in the Bashas’ stores throughout Southern and Eastern Arizona to support breast cancer research at the University of Arizona Cancer Center.

“We are delighted to join forces with these great community companies in our mission to prevent and cure cancer,” said Anne Cress, PhD, interim director of the UA Cancer Center. “Our researchers are on the front line of the search for the causes and cures for breast cancer.”

Blood Cell Gene Expression can Predict Outcomes in Patients With Idiopathic Pulmonary Fibrosis (IPF), Study Finds

A new study shows that changes in the expression of genes in the blood can predict poor outcomes of patients with idiopathic pulmonary fibrosis (IPF). The study results suggest that these potential biomarkers should be evaluated further for prioritizing lung transplantation and for drug studies.

Pages

Subscribe to RSS - Translational and Regenerative Medicine